Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis

被引：0
|
作者：
Torbjørn Wisløff
Randi M Selmer
Sigrun Halvorsen
Atle Fretheim
Ole F Norheim
Ivar Sønbø Kristiansen
机构：
[1] University of Oslo,Institute of Health and Society
[2] Norwegian Knowledge Centre for the Health Services,Department of Cardiology
[3] Norwegian Institute of Public Health,undefined
[4] Oslo University Hospital,undefined
[5] University of Bergen,undefined
来源：
BMC Cardiovascular Disorders | / 12卷
关键词：
Calcium Channel Blocker; Antihypertensive Drug; Thiazide; Angiotensin Receptor Blocker; African American Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
    Wisloff, Torbjorn
    Selmer, Randi M.
    Halvorsen, Sigrun
    Fretheim, Atle
    Norheim, Ole F.
    Kristiansen, Ivar Sonbo
    BMC CARDIOVASCULAR DISORDERS, 2012, 12
  • [2] COST-EFFECTIVENESS OF NOVEL DRUGS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
    Silbernagel, Gunther
    Bilger, Marcel
    ATHEROSCLEROSIS, 2024, 395
  • [3] Smoking cessation for primary prevention of cardiovascular disease: A cost-effectiveness analysis
    Kinderen, AJD
    Oh, F
    De Laet, C
    VALUE IN HEALTH, 2004, 7 (06) : 692 - 693
  • [4] Primary prevention of cardiovascular disease: a cost-effectiveness comparison
    Franco, O
    De Laet, C
    Der Kinderen, A
    Peeters, A
    Bonneux, L
    EUROPEAN HEART JOURNAL, 2004, 25 : 122 - 122
  • [5] Primary prevention of cardiovascular disease: Cost-effectiveness comparison
    Franco, Oscar H.
    Kinderen, Arno J. der
    De Laet, Chris
    Peeters, Anna
    Bonneux, Luc
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (01) : 71 - 79
  • [6] Primary prevention of cardiovascular disease: A cost-effectiveness comparison
    Franco, OH
    De Laet, C
    Kinderen, AD
    Peeters, A
    Bonneux, L
    CIRCULATION, 2004, 110 (17) : 802 - 802
  • [7] Cost-effectiveness of antihypertensives in the primary prevention of cardiovascular disease
    Duran, O. H. Franco
    Kinderen, A. Der
    Steyerberg, E.
    EUROPEAN HEART JOURNAL, 2006, 27 : 578 - 578
  • [8] Pravastatin cost-effectiveness for primary prevention of cardiovascular disease in the US
    Hay, JW
    Yuan, Y
    Ford, I
    McGuire, A
    Shepherd, J
    CIRCULATION, 1997, 96 (08) : 1017 - 1017
  • [9] THE COST-EFFECTIVENESS OF ANTIHYPERTENSIVE DRUGS
    KAPLAN, NM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (21): : 2888 - 2889
  • [10] GENERALIZED COST-EFFECTIVENESS ANALYSIS OF PHARMACEUTICAL INTERVENTIONS FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN THAILAND
    Khonputsa, P.
    Veerman, J. L.
    Bertram, M.
    Vos, T.
    VALUE IN HEALTH, 2010, 13 (07) : A520 - A520
12345